Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Share:
Related GILD
What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors?
5 NASDAQ Healthcare Stocks With The Highest EPS
Seeking Alpha's Biotech Weekly: J&J-Achillion Vs. Gilead, MannKind's Marketing, And More (Seeking Alpha)
Related CELG
Goldman Sachs Previews ASCO Cancer Conference With Amgen, Celgene And Clovis Oncology
Morgan Stanley Looks Over Celgene's Quarter
What Is 'Smart Money' Shorting In This Psychotically Bullish Market (Seeking Alpha)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas

 

Related Articles (ALXN + BIIB)

Around the Web, We're Loving...

Get Benzinga's Newsletters